Intended Use

The Ahead 200 is indicated as an adjunct to standard clinical practice to aid evaluation of patients considered for head CT after closed head injury, presenting as mild traumatic brain injury within 24 hours, ages 18-80. It is not a substitute for CT and is for physicians trained in device use.

Technology

The device is a portable, non-invasive EEG system composed of a handheld unit and disposable electrode headset. It records, processes, and analyzes frontal EEG signals using standard quantitative EEG parameters such as absolute power, relative power, asymmetry, coherence, and fractal dimension. The system uses the Harmony classification algorithm to assist diagnosis. There are two models, military (M-200) including Military Acute Concussion Evaluation (MACE) cognitive tests, and civilian (CV-200).

Performance

Performance testing included software and hardware verification, system performance validation, algorithm performance, safety and electromagnetic compatibility testing, biocompatibility, and reliability assessments. The device met applicable standards including IEC 60601-1, IEC 60601-2-26, ISO 10993-1, and ANSI/AAMI EC12. Testing demonstrated substantial equivalence to the predicate device, the BrainScope Ahead 100.

Predicate Devices

No predicate devices specified

Device Timeline

  • 1

    Submission

    12/22/2014

    4 months
  • 2

    FDA Approval

    5/15/2015

Other devices from BRAINSCOPE COMPANY, INC.

Ready to Sharpen Your Edge?

Join hundreds of your peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.